167 related articles for article (PubMed ID: 38531846)
61. CEP55 promotes the proliferation and invasion of tumour cells via the AKT signalling pathway in osteosarcoma.
Xu L; Xia C; Sheng F; Sun Q; Xiong J; Wang S
Carcinogenesis; 2018 Apr; 39(4):623-631. PubMed ID: 29579156
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
63. Gamabufotalin suppressed osteosarcoma stem cells through the TGF-β/periostin/PI3K/AKT pathway.
Ma K; Zhang C; Li W
Chem Biol Interact; 2020 Nov; 331():109275. PubMed ID: 33010222
[TBL] [Abstract][Full Text] [Related]
64. USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisation.
Wu X; Wang H; Zhu D; Chai Y; Wang J; Dai W; Xiao Y; Tang W; Li J; Hong L; Pei M; Zhang J; Lin Z; Wang J; Li A; Liu S
Cell Death Dis; 2021 Dec; 13(1):10. PubMed ID: 34930901
[TBL] [Abstract][Full Text] [Related]
65. DPY30 promotes the growth and survival of osteosarcoma cell by regulating the PI3K/AKT signal pathway.
Cheng G; An F; Cao Z; Zheng M; Zhao Z; Wu H
Eur J Histochem; 2023 Jan; 67(1):. PubMed ID: 36546421
[TBL] [Abstract][Full Text] [Related]
66. MicroRNA miR-23b-3p promotes osteosarcoma by targeting ventricular zone expressed PH domain-containing 1 (VEPH1)/phosphatidylinositol 3-kinase/protein kinase B (PI3K/AKT) pathway.
Fan L; Cao X; Lei Y
Bioengineered; 2021 Dec; 12(2):12568-12582. PubMed ID: 34903122
[TBL] [Abstract][Full Text] [Related]
67. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
[TBL] [Abstract][Full Text] [Related]
68. MicroRNA-802 promotes the progression of osteosarcoma through targeting p27 and activating PI3K/AKT pathway.
Gao LF; Jia S; Zhang QM; Xia YF; Li CJ; Li YH
Clin Transl Oncol; 2022 Feb; 24(2):266-275. PubMed ID: 34318428
[TBL] [Abstract][Full Text] [Related]
69. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
[TBL] [Abstract][Full Text] [Related]
70. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.
Huang H; Lu Q; Yuan X; Zhang P; Ye C; Wei M; Yang C; Zhang L; Huang Y; Luo X; Luo J
Chem Biol Interact; 2022 Sep; 365():110068. PubMed ID: 35917943
[TBL] [Abstract][Full Text] [Related]
71. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro.
Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ
Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695
[TBL] [Abstract][Full Text] [Related]
72. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway.
Zhao X; Li J; Yu D
Int J Mol Med; 2019 Nov; 44(5):1833-1843. PubMed ID: 31545400
[TBL] [Abstract][Full Text] [Related]
73. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.
Chen B; Zheng ZY; Yang JZ; Li XG
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3611-3620. PubMed ID: 31114985
[TBL] [Abstract][Full Text] [Related]
74. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro.
Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL
Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625
[TBL] [Abstract][Full Text] [Related]
75. An Exploration of Osteosarcoma Metastasis Diagnostic Markers Based on Tumor-Associated Neutrophils.
Tan S; Chao R
Discov Med; 2023 Jun; 35(176):300-311. PubMed ID: 37272097
[TBL] [Abstract][Full Text] [Related]
76. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
[TBL] [Abstract][Full Text] [Related]
77. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
Zhang Y; Cheng H; Li W; Wu H; Yang Y
Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
[TBL] [Abstract][Full Text] [Related]
78. Sema4D/Plexin-B1 promotes the progression of osteosarcoma cells by activating Pyk2-PI3K-AKT pathway.
Li C; Wan L; Wang P; Guan X; Li C; Wang X
J Musculoskelet Neuronal Interact; 2021 Dec; 21(4):577-583. PubMed ID: 34854398
[TBL] [Abstract][Full Text] [Related]
79. Isoliquiritigenin Suppresses Osteosarcoma U2OS Cell Proliferation and Invasion by Regulating the PI3K/Akt Signalling Pathway.
Chen J; Liu C; Yang QQ; Ma RB; Ke Y; Dong F; Wu XE
Chemotherapy; 2018; 63(3):155-161. PubMed ID: 29936511
[TBL] [Abstract][Full Text] [Related]
80. LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors
Zhang Q; Tang X; Zhou Y; Chen X; Peng K; Jiang R; Liu Z; Song X; Xia H
Cancer Biol Ther; 2023 Dec; 24(1):2198904. PubMed ID: 37211864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
